Amitriptyline plasma levels and therapeutic response. 1976

V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs

Eighteen depressed outpatients were treated for 6 wk with amitriptyline. Clinical improvement was monitored using the Hamilton Depression Rating Scale administered by two psychiatrists blind to the tricyclic used for treatment, dosage, and plasma levels. Amitriptyline and its desmethyl metabolite, notriptyline, were assayed twice weekly by gas chromatography-mass fragmentography. For the 17 patients having total tricyclic plasma levels between 0 and 250 ng/ml, there was a negative correlation between the Hamilton score and the mean total tricyclic level (p less than 0.01) and amitriptyline level (p less than 0.005). The mean nortriptyline level did not significantly correlate with the Hamilton score. The 10 patients having mean total tricyclic levels above 95 ng/ml had lower median Hamilton scores at week 3 (p less than 0.025) and at week 6 (p less than 0.0025) than those whose tricyclics were lower. The percentage of recovered patients increases significantly as the plasma levels rise to 250 ng/ml, the maximum plasma level considered in this study.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin

Related Publications

V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
December 1977, Pharmakopsychiatrie, Neuro-Psychopharmakologie,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
January 1978, Psychopharmacology bulletin,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
October 1986, Ceskoslovenska psychiatrie,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
April 1982, Psychiatry research,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
December 1977, Clinical pharmacology and therapeutics,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
January 1987, Psychiatria polska,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
January 1978, Communications in psychopharmacology,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
October 1976, Clinical pharmacology and therapeutics,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
January 1978, Psychopharmacology bulletin,
V E Ziegler, and B T Co, and J R Taylor, and P J Clayton, and J T Biggs
July 2003, Pharmacopsychiatry,
Copied contents to your clipboard!